Enovis (ENOV) Cash from Financing Activities (2010 - 2026)
Enovis (ENOV) reported Cash from Financing Activities of $26.0 million for Q2 2026, down 49.16% year-over-year from $51.2 million in Q2 2025, and up 135.69% on a QoQ basis from -$72.9 million in Q4 2025.
Enovis (ENOV) has 17 years of Cash from Financing Activities data on file, last reported at $26.0 million in Q2 2026.
- Quarterly Cash from Financing Activities fell 49.16% year-over-year to $26.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$77.6 million (down 331.74% YoY) and the FY2025 annual result came in at -$52.4 million, down 106.19% from the prior year.
- Cash from Financing Activities advanced to $26.0 million in Q2 2026 per ENOV's latest filing, from -$72.9 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $864.5 million in Q1 2024 and bottomed at -$495.5 million in Q3 2022.
- The 5-year median for Cash from Financing Activities is $2.5 million (2024), against an average of $28.4 million.
- The widest annual swing landed in 2024, when Cash from Financing Activities soared 3429.02%; it then plunged 24837.16% in 2025.
- Tracing ENOV's Cash from Financing Activities over 5 years: stood at $41.6 million in 2022, then slumped by 93.3% to $2.8 million in 2023, then slumped by 819.97% to -$20.1 million in 2024, then plunged by 263.12% to -$72.9 million in 2025, then soared by 135.69% to $26.0 million in 2026.
- Per Business Quant, the three latest ENOV Cash from Financing Activities figures stand at $26.0 million (Q2 2026), -$72.9 million (Q4 2025), and -$36.9 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn | 26.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 26.02 Mn |
| Apr 3, 2026 | 26.02 Mn |
| Dec 31, 2025 | -72.92 Mn |
| Dec 31, 2025 | -72.92 Mn |
| Oct 3, 2025 | -36.91 Mn |
| Oct 3, 2025 | -36.91 Mn |
| Jul 4, 2025 | 6.23 Mn |
| Jul 4, 2025 | 6.23 Mn |
| Apr 4, 2025 | 51.19 Mn |
| Apr 4, 2025 | 51.19 Mn |
| Dec 31, 2024 | -20.08 Mn |
| Dec 31, 2024 | -20.08 Mn |
| Sep 27, 2024 | -148,000.00 |
| Sep 27, 2024 | -148,000.00 |
| Jun 28, 2024 | 2.51 Mn |
| Jun 28, 2024 | 2.51 Mn |
| Mar 29, 2024 | 864.54 Mn |
| Mar 29, 2024 | 864.54 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Sep 29, 2023 | -13.70 Mn |
| Sep 29, 2023 | -13.70 Mn |
| Jun 30, 2023 | 114.21 Mn |
| Jun 30, 2023 | 114.21 Mn |
| Mar 31, 2023 | 24.50 Mn |
| Mar 31, 2023 | 24.50 Mn |
| Dec 31, 2022 | 41.63 Mn |
| Dec 31, 2022 | 41.63 Mn |
| Sep 30, 2022 | -456,000.00 |
| Sep 30, 2022 | -456,000.00 |
| Jul 1, 2022 | -495.48 Mn |
| Jul 1, 2022 | -495.48 Mn |
| Apr 1, 2022 | -10.82 Mn |
| Apr 1, 2022 | -10.82 Mn |
| Dec 31, 2021 | 473.07 Mn |
| Dec 31, 2021 | 473.07 Mn |
| Oct 1, 2021 | 40.15 Mn |
| Oct 1, 2021 | 40.15 Mn |
| Jul 2, 2021 | -635.97 Mn |
| Jul 2, 2021 | -635.97 Mn |
| Apr 2, 2021 | 707.65 Mn |
| Apr 2, 2021 | 707.65 Mn |
| Dec 31, 2020 | -6.07 Mn |
| Dec 31, 2020 | -6.07 Mn |
| Oct 2, 2020 | -48.17 Mn |
| Oct 2, 2020 | -48.17 Mn |
| Jul 3, 2020 | -322.55 Mn |
| Jul 3, 2020 | -322.55 Mn |
| Apr 3, 2020 | 245.14 Mn |
| Apr 3, 2020 | 245.14 Mn |
| Dec 31, 2019 | -1.72 Bn |
| Dec 31, 2019 | -1.72 Bn |
| Sep 27, 2019 | -88.13 Mn |
| Sep 27, 2019 | -88.13 Mn |
| Jun 28, 2019 | -60.00 Mn |
| Jun 28, 2019 | -60.00 Mn |
| Mar 29, 2019 | 3.24 Bn |
| Mar 29, 2019 | 3.24 Bn |
| Dec 31, 2018 | 53.79 Mn |
| Dec 31, 2018 | 53.79 Mn |
| Sep 28, 2018 | 14.80 Mn |
| Sep 28, 2018 | 14.80 Mn |
| Jun 29, 2018 | -173.15 Mn |
| Jun 29, 2018 | -173.15 Mn |
| Mar 30, 2018 | 57.41 Mn |
| Mar 30, 2018 | 57.41 Mn |
| Dec 31, 2017 | -286.62 Mn |
| Dec 31, 2017 | -286.62 Mn |
| Sep 29, 2017 | 1.26 Mn |
| Sep 29, 2017 | 1.26 Mn |
| Jun 30, 2017 | 52.20 Mn |
| Jun 30, 2017 | 52.20 Mn |
| Mar 31, 2017 | -47.29 Mn |
| Mar 31, 2017 | -47.29 Mn |
| Dec 31, 2016 | -72.08 Mn |
| Dec 31, 2016 | -72.08 Mn |
| Sep 30, 2016 | -25.99 Mn |
| Sep 30, 2016 | -25.99 Mn |
| Jul 1, 2016 | -41.87 Mn |
| Jul 1, 2016 | -41.87 Mn |
| Apr 1, 2016 | -5.29 Mn |
| Apr 1, 2016 | -5.29 Mn |
| Dec 31, 2015 | -144.19 Mn |
| Dec 31, 2015 | -144.19 Mn |
| Sep 25, 2015 | 148.42 Mn |
| Sep 25, 2015 | 148.42 Mn |
| Jun 26, 2015 | -64.32 Mn |
| Jun 26, 2015 | -64.32 Mn |
| Mar 27, 2015 | -71.17 Mn |
| Mar 27, 2015 | -71.17 Mn |
| Dec 31, 2014 | -136.85 Mn |
| Dec 31, 2014 | -136.85 Mn |
| Sep 26, 2014 | -179.56 Mn |
| Sep 26, 2014 | -179.56 Mn |
| Jun 27, 2014 | 719.33 Mn |
| Jun 27, 2014 | 719.33 Mn |
| Mar 28, 2014 | 247.12 Mn |
| Mar 28, 2014 | 247.12 Mn |
| Dec 31, 2013 | -89.43 Mn |
| Dec 31, 2013 | -89.43 Mn |
| Sep 27, 2013 | -25.67 Mn |
| Sep 27, 2013 | -25.67 Mn |
| Jun 28, 2013 | 280.68 Mn |
| Jun 28, 2013 | 280.68 Mn |
| Mar 29, 2013 | -210.63 Mn |
| Mar 29, 2013 | -210.63 Mn |
| Dec 31, 2012 | -16.11 Mn |
| Dec 31, 2012 | -16.11 Mn |
| Sep 28, 2012 | -15.93 Mn |
| Sep 28, 2012 | -15.93 Mn |
| Jun 29, 2012 | -66.48 Mn |
| Jun 29, 2012 | -66.48 Mn |
| Mar 30, 2012 | 2.28 Bn |
| Mar 30, 2012 | 2.28 Bn |
| Dec 31, 2011 | 38.05 Mn |
| Dec 31, 2011 | 38.05 Mn |
| Sep 30, 2011 | -5.08 Mn |
| Sep 30, 2011 | -5.08 Mn |
| Jul 1, 2011 | -2.65 Mn |
| Jul 1, 2011 | -2.65 Mn |
| Apr 1, 2011 | 2.43 Mn |
| Apr 1, 2011 | 2.43 Mn |
| Dec 31, 2010 | -2.39 Mn |
| Dec 31, 2010 | -2.39 Mn |
| Oct 1, 2010 | -2.44 Mn |
| Oct 1, 2010 | -2.44 Mn |